2024-07-03T12:03:58-04:00 2023-12-31 341738426 CORBETS & ASSOCIATES INC 33595 BAINBRIDGE RD STE 205 SOLON OH 44139 990 2023-01-01 262890160 (ACPMP)APPENDIX CANCERPSEUDOMYXOMA PERITONEI RESEARCH FOUNDATION ACPM 8332276773 491 BALTIMORE PIKE 177 SPRINGFIELD PA 190643810 JAMES CARROLL PRESIDENT 2024-06-10 true JAMES CARROLL 999009999 true KATHLEEN HOOVER P00174805 4403490463 2024-06-08 2023 2023-04-26 12:10:37Z JAMES CARROLL 663504 false X ACPMP.ORG X 2008 OH TO FUND AND SUPPORT PROMISING RESEARCH TO FIND A CURE FOR PSEUDOMYXOMA PERITONEI (PMP),APPENDIX CANCER, AND RELATED PERITONEAL SURFACE MALIGNANCIES (PSM), AND TO FUND EDUCATIONAL PROGRAMS FOR PHYSICIANS AND PATIENTS ABOUT THESE DISEASES. 3 3 3 25 0 485452 558965 0 -5357 50675 -12947 -17845 467148 591795 75000 25000 0 77483 68433 0 80850 75545 145559 228028 238992 239120 352803 1699668 2054563 0 1699668 2054563 X TO FUND AND SUPPORT PROMISING RESEARCH TO FIND A CURE FOR PSEUDOMYXOMA PERITONEI (PMP),APPENDIX CANCER, AND RELATED PERITONEAL SURFACE MALIGNANCIES (PSM), AND TO FUND EDUCATIONAL PROGRAMS FOR PHYSICIANS AND PATIENTS ABOUT THESE DISEASES. false false 32500 25000 AWARDED AND FUNDED RESEARCH GRANTS 56169 SYMPOSIUM PARTICIPATION/SCHOLARSHIPS & SPONSORSHIP 46280 PROVIDE EDUCATIONAL INFORMATION ON PMP TO PATIENTS, FAMILIES OF PATIENTS AND ANY OTHER INTERESTED PARTIES THRU EDUCATIONAL SESSIONS, CONFERENCE ATTENDENCE/EXHIBITS AND WEB 134949 true true false false false false false false false false false false false false false false false false false false false false false false true false false true false false false false false false true false false false true false false false false false false false false true 0 0 false 3 true false false false false false false false false X 3 3 false false false false false false false true true false false true true true true false false false false false PA X JUDITH CULBERTSON 8332276773 179 KINGSWOOD COURT GLEN MILLS PA 19342 X JAMES CARROLL PRESIDENT X X 0 0 0 JUDITH CULBERTSON TREAS/VP X X 0 0 0 DEBORAH SHELTON SECY/EXEC DI X X 0 0 0 false false false 298131 260834 50558 558965 50665 50665 50568 50558 10 10 10 298131 18559 -18559 3306 2592 714 714 591795 10 51379 25000 25000 61764 25276 9556 26932 1846 923 923 4823 1974 746 2103 227 227 4000 4000 1803 1803 2393 2393 12380 7200 75 5105 7208 7208 1685 1685 SYMPOSIUMS 48961 48961 DUES & FEES 38490 7500 3980 27010 MERCHANT FEES 15292 15292 COMMUNICATIONS - ZOOM 4981 4981 8139 5926 531 1682 238992 134949 23193 80850 54302 80241 1640104 331634 5262 10309 1632379 1699668 2054563 0 0 X 1699668 2026505 28058 1699668 2054563 1699668 2054563 352803 2092 X true false false X 304151 390119 871328 485452 558965 2610015 11626 12386 3306 27318 304151 390119 882954 497838 562271 2637333 2637333 2661 1077 18012 12386 50665 84801 2661 1077 18012 12386 50665 84801 1296 1296 306812 391196 900966 511520 612936 2723430 0.96840 0.99760 0.03000 0.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED ANNUAL PA CANCE 171657 171657 15511 EVENTS > 5,000 122214 122214 2520 4 293871 293871 18031 18031 -18031 false MEMORIAL SLOAN KETTERING CANCER CTR MICHAEL FOOTE MD 160 EAST 53RD STREET NEW YORK NY 10022 131924236 501C3 25000 RESEARCH 1 SCHEDULE I, PAGE 1, PART I, LINE 2 THE ORGANIZATION INITIALLY UTILIZED THE SERVICES OF NATIONAL ORGANIZATION FOR RARE DISEASE (NORD) TO SELECT GRANT RECIPIENTS AND ADMINISTER THE GRANTS. NORD HAS A QUALIFED MEDICAL ADVISORY BOARD TO INDEPENDENTLY REVIEW AND EVALUATE GRANT PROPOSALS. NORD MAY ALSO PROVIDE ADDITIONAL FUNDING TO PREVIOUSLY APPROVED GRANT RECIPIENTS. IN THIS INSTANCE NORD WILL PROVIDE RESEARCH UPDATES EVERY SIX MONTHS TO THE FOUNDATION. EFFECTIVE BEGINNING DURING 2022, THE ORGANIZATION ESTABLISHED AN INDEPENDENT SCIENTIFIC ADVISORY BOARD COMPRISED OF PHYSICIANS AND OTHER EXPERTS WITH BACKGROUNDS AND EXPERIENCE IN THESE TYPES OF DISEASES TO REVIEW AND APPROVE RESEARCH GRANTS. THE ORGANIZATION HAS ALSO INVESTED IN SOFTWARE TO ASSIST THE ACTING EXCECUTIVE DIRECTOR AND BOARD IN MONITORING EXPENDITURES AND RESEARCH PROGRESS. PROGRESS REPORTS ARE REQUIRED ON AN ANNUAL BASIS. THE ANNUAL PROGRESS REVIEW BY PROTOCOL OCCURS BEFORE THE 2ND YEAR FUNDING IS RELEASED. DR ANDREANA N HOLOWATYJ ADVISORY BOARD MEMBR YEAR 2 AWARDED NOT FUNDED RESEARCH GRANT SCHEDULE L, PART V DR HOLOWATYJ WAS AWARDED A 50,000 2 YEAR GRANT FOR HER RESEARCH PROJECT AT VANDERBILT UNIVERSITY MEDICAL CENTER PRIOR TO HER JOINING THE SCIENTIFIC ADVISORY BOARD. SHE DID NOT PARTICIPATE IN THE PROCESS THAT AWARDED THE GRANT; HOWEVER, SINCE THE GRANT IS FUNDED OVER TWO YEARS, HER TENURE ON THE ADVISORY BOARD CAN OVERLAP THE RESEARCH AND THE ACTUAL FUNDING. PROGRESS WILL BE REVIEWED PER PROTOCOL WITH THE OTHER SAB MEMBERS AND AN ALTERNATIVE SAB REVIEWER TO AVOID CONFLICT OF INTEREST. THE SECOND PAYMENT WAS NOT MADE DURING 2023 AS THE SAB IS WAITING FOR ADDITIONAL INFO/TESTING RESULTS, BUT IS ANTICIPATED TO BE FUNDED IN 2024. X 1 50558 false false false FORM 990 - ORGANIZATION'S MISSION TO FUND AND SUPPORT PROMISING RESEARCH TO FIND A CURE FOR PSEUDOMYXOMA PERITONEI (PMP),APPENDIX CANCER, AND RELATED PERITONEAL SURFACE MALIGNANCIES (PSM), AND TO FUND EDUCATIONAL PROGRAMS FOR PHYSICIANS AND PATIENTS ABOUT THESE DISEASES. FORM 990, PAGE 1, PART I, LINE 6 BOARD IS ALL VOLUNTEER AND EVENT ORGANIZERS ARE ALSO VOLUNTEER. FORM 990, PAGE 6, PART VI, LINE 11B THE PRESIDENT AND TREASURER REVIEW AND APPROVE THE 990 AND ENSURE ALL BOARD MEMBERS RECEIVE A COPY.COMMENTS OR QUESTIONS, IF ANY, ARE ADDRESSED EITHER AT A BOARD MEETING OR VIA E-MAIL. FORM 990, PAGE 6, PART VI, LINE 12C EACH BOARD MEMBER ANNUALLY SIGNS A CONFLICT OF INTEREST STATEMENT. AT THE START OF EACH BOARD MEETING MEMBERS ARE REQUIRED TO DISCLOSE ANY CONFLICT OF INTEREST OR POTENTIAL CONFLICT OF INTEREST ON AGENDA TOPICS. THE SECRETARY IS RESPONSIBLE FOR REVIEWING AND MAINTAINING CONFLICT OF INTEREST DISCLOSURES. FORM 990, PAGE 6, PART VI, LINE 19 GOVERNING DOUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. CONTACT INFORMATION IS LISTED ON THE ORGANIZATION'S WEBSITE.